Zoetis Investor Overview (04/09/2025 00: 00
ZTS
Corporate Overview
April 2025
Our Purpose
To nurture the world and humankind by advancing care for animals.
Our Vision
To be the most trusted and valued animal health company, shaping the future of animal care through our innovation, customer obsession and purpose-driven colleagues.
2 Zoetis Corporate Overview
Zoetis at a Glance
70+
$9.3B
7
8
Years of experience
Annual revenue
Major product categories
Core species
We provide:
100+
23
68%
•
Medicines
31%
•
Vaccines
Countries with market presence
Manufacturing sites
Revenue from companion animal products1
Revenue from livestock products1
•
Genetic tests
1,600
4,050
13,800
•
Precision
Approximate R&D colleagues
Approx. field force members
Approx. colleagues worldwide
animal health
3 Zoetis Corporate Overview
Note: Facts and figures shown are as of Dec. 31, 2024
1 Excludes revenue associated with Client Supply Services and Human Health, which represented 1% of total 2024 revenue.
Our Executive Team
Kristin Peck
Chief Executive Officer
4 Zoetis Corporate Overview
Nick Ashton
Executive Vice President and
President, Global Manufacturing
and Supply
Wetteny Joseph
Executive Vice President and
Chief Financial Officer
Jamie Brannan
Rimma Driscoll
Jeannette Ferran
Executive Vice President and
Executive Vice President, Head
Astorga
Chief Commercial Officer
of Global Strategy, Commercial
Executive Vice President,
and Business Development, and
Corporate Affairs
Global BioDevices
Chief Sustainability Officer
Roxanne Lagano
Rob Polzer
Keith Sarbaugh
Executive Vice President,
Executive Vice President and
Executive Vice President and
General Counsel and Corporate
President, Research and
Chief Digital &
Secretary
Development
Technology Officer
Julie Fuller
Executive Vice President,
Chief Human Resources Officer
and Global Operations
Our Core Beliefs form the foundation of our culture
5 Zoetis Corporate Overview
Our Strategic
Priorities
Lead through
Deliver an
Power our
Support a
Advance
Perform with
innovation
exceptional
business
workplace
sustainability
excellence
across our
experience
through digital
where our
in animal
and agility
diverse
to delight our
solutions and
colleagues
health for a
portfolio
customers
data insights
can thrive
better future
6 Zoetis Corporate Overview
Innovating
Across the
Continuum
of Care
PREDICT
PREVENT
DETECT
TREAT
Genetics Vaccines,
Data
Diagnostics
Medicines
robotics
analytics
and
and sensors
automation
7 Zoetis Corporate Overview
Diverse,
Durable and
Innovative
Portfolio
Diversity across geographies, species and therapeutic areas drives steady performance
7
major product
categories
171
blockbusters
~300
product lines
8
core species
~302
year average market life of key brands in portfolio
>2,000
new products and lifecycle
innovations introduced
in last 12 years
8 Zoetis Corporate Overview
1
Number of blockbuster products with revenues of $100M or more as of year-end 2024
2
Market life refers to the number of years a product has been commercially available.
Leading the industry across the Continuum of Care over 10 years with 17 blockbusters1
ANTI-INFECTIVES
DERMATOLOGY
PAIN & SEDATION
DIAGNOSTICS
OTHER PHARM
PARASITICIDES
VACCINES
9 Zoetis Corporate Overview
1 Number of blockbuster products with revenues of $100M or more as of year-end 2024
World Leader in Animal Health1
By Species
Companion Animal
#1
Cattle
#1
Fish3
#1
Market Leader in Species Representing ~90% of Our Portfolio by Revenue3
Swine#3
Poultry#6
By Product Category
Other Pharma2
#1
Anti-Infectives #1
Vaccines#2 (Biologicals)
Diagnostics3#3
Parasiticides #2
By Geography
North America
#1
Latin America
#1
Asia
#1
Eastern Europe
#2
Western Europe
#2
High Growth Franchise
Areas3
Dermatology #1
Pet Pain
#1
Pet Parasiticides
#2
10 Zoetis Corporate Overview
Disclaimer
Zoetis Inc. published this content on April 09, 2025, and is solely responsible for the information contained herein. Distributed via , unedited and unaltered, on April 09, 2025 at 14:17 UTC.